Concepedia

Eileen Hu

EH

10

Publications

972

Citations

10

H-Index

2014

Active since

Affiliations

The Ohio State University(Current)

University of California, Los Angeles

Harvard University

Dana-Farber Cancer Institute

Scripps Research Institute

Eileen Hu is an author at The Ohio State University specializing in medicine, biochemistry, and molecular pharmacology.

Top concepts

MedicineBiochemistryHealthBiologyLongevitySymbiosisMetabolismPhysiologyEngineeringCell Biology

Publications per year

2014–2024

10

Publications

10

The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR

R Chin, Xudong Fu, Melody Y. Pai et al. · Nature · 2014 · 598 citations · Full text

Lifespan Extension, Metabolite α-Ketoglutarate Extends, Energy Metabolism +13

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

Raghu Vannam, Jan Fehmi Sayılgan, Samuel Ojeda et al. · Cell chemical biology · 2021 · 151 citations · Full text

Molecular Pharmacology, Transcriptional Regulation, Biochemistry +7

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

Shuai Dong, Bonnie K. Harrington, Eileen Hu et al. · Journal of Clinical Investigation · 2018 · 52 citations · Full text

PERSIST platform provides programmable RNA regulation using CRISPR endoRNases

Breanna DiAndreth, Noreen Wauford, Eileen Hu et al. · Nature Communications · 2022 · 45 citations · Full text

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

Swagata Goswami, Rajeswaran Mani, Jessica Nunes et al. · Blood · 2021 · 37 citations · Full text

Targetable Driver, Hematological Malignancy, C-myc/p21 Axis +15

Rows per page

1–5 of 10